Validation of the Korean version of the 16-Item Prodromal Questionnaire in a Non-Help-Seeking College Population

키워드

참고문헌 (40)

1. McGorry PD, "Early intervention in psychotic disorders: detection and treatment of the first episode and the critical early stages", Med J Aust, 187(7 Suppl), pp.S8~S10 (2007)
2. Addington J, "Duration of untreated psychosis in community treatment settings in the United States", Psychiatr Serv, 66, pp.753~756 (2015)[DOI]
3. 김성완, "Effects of Group Cognitive-Behavioral Therapy in Young Patients in the Early Stage of Psychosis", PSYCHIATRY INVESTIGATION, 14(5), pp.609~617 (2017), 대한신경정신의학회[DOI]
4. Schimmelmann BG, "Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort", J Psychiatr Res, 42, pp.982~990 (2008)[DOI]
5. Kane JM, "Comprehensive versus usual community care for firstepisode psychosis: 2-year outcomes from the NIMH RAISE early treatment program", Am J Psychiatry, 173, pp.362~372 (2016)[DOI]
6. 김성완, "Design and Methodology of the Korean Early Psychosis Cohort Study", PSYCHIATRY INVESTIGATION, 14(1), pp.93~99 (2017), 대한신경정신의학회[DOI]
7. Yoo J, "A study of duration of untreated psychosis (DUP) for first episode psychosis", Ment Health, 2, pp.12~16 (2011)
8. Hutton P, "Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis", Psychol Med, 44, pp.449~468 (2014)[DOI]
9. Amminger GP, "Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids", Transl Psychiatry, 5, pp.e495~ (2015)[DOI]
10. Yung AR, "Monitoring and care of young people at incipient risk of psychosis", Schizophr Bull, 22, pp.283~303 (1996)[DOI]
11. Kim SW, "Relationship between erythrocyte fatty acid composition and psychopathology in the vienna omega-3 study", PLoS One, 11, pp.e0151417~ (2016)[DOI]
12. Kim SW, "Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis", Schizophr Res, 158, pp.39~44 (2014)[DOI]
13. Nelson B, "Long-term follow-up of a group at ultra high risk (prodromal) for psychosis: the PACE 400 study", JAMA Psychiatry, 70, pp.793~802 (2013)[DOI]
14. American Psychiatric-Association, "Diagnostic and Statistical Manual of Mental Disorder. 5th Ed." (2013), American Psychiatric Publishing
15. Yung AR, "Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states", Aust N Z J Psychiatry, 39, pp.964~971 (2005)[DOI]
16. Fusar-Poli P, "Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS", Psychiatry J, 2016, pp.7146341~ (2016)
17. Miller TJ, "Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability", Schizophr Bull, 29, pp.703~715 (2003)[DOI]
18. Addington J, "Screening tools for clinical high risk for psychosis", Early Interv Psychiatry, 9, pp.345~356 (2015)[DOI]
19. Chung YC, "Validation of the Korean version of the Eppendorf Schizophrenia Inventory as a screening measure to detect adolescents at ultra-high risk for psychosis", Early Interv Psychiatry, 7, pp.71~79 (2013)[DOI]
20. Ising HK, "The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population", Schizophr Bull, 38, pp.1288~1296 (2012)[DOI]
21. Loewy RL, "The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes", Schizophr Res, 79, pp.117~125 (2005)[DOI]
22. Mass R, "Introducing the Eppendorf Schizophrenia Inventory (ESI) as a psychometric method for schizotypy research", Pers Individ Dif, 42, pp.525~534 (2007)[DOI]
23. Loewy RL, "Prodromal psychosis screening in adolescent psychiatry clinics", Early Interv Psychiatry, 6, pp.69~75 (2012)[DOI]
24. Sheehan DV, "The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10", J Clin Psychiatry, 59(Suppl 20), pp.22~33 (1998)
25. Han C, "Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study", Compr Psychiatry, 49, pp.218~223 (2008)[DOI]
26. Spitzer RL, "Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire", JAMA, 282, pp.1737~1744 (1999)[DOI]
27. Kobayashi H, "A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population", Schizophr Res, 106, pp.356~362 (2008)[DOI]
28. Loewy RL, "Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B)", Schizophr Res, 129, pp.42~46 (2011)[DOI]
29. Muller M, "The Self-screen-Prodrome as a short screening tool for pre-psychotic states", Schizophr Res, 123, pp.217~224 (2010)[DOI]
30. Owoso A, "Validation of a modified version of the PRIME screen for psychosis-risk symptoms in a non-clinical Kenyan youth sample", Compr Psychiatry, 55, pp.380~387 (2014)[DOI]
31. Loewy RL, "Self-report of attenuated psychotic experiences in a college population", Schizophr Res, 93, pp.144~151 (2007)[DOI]
32. O'Toole BI, "Screening for low prevalence disorders", Aust N Z J Psychiatry, 34(Suppl), pp.S39~S46 (2000)[DOI]
33. Post SG, "Preventing schizophrenia and Alzheimer disease: comparative ethics", Schizophr Res, 51, pp.103~108 (2001)[DOI]
34. Kim SW, "Are current labeling terms suitable for people who are at risk of psychosis?", Schizophr Res, 188, pp.172~177 (2017)[DOI]
35. Yang LH, "Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis", Schizophr Res, 168, pp.9~15 (2015)[DOI]
36. Escher S, "Independent course of childhood auditory hallucinations: a sequential 3-year follow-up study", Br J Psychiatry Suppl, 43, pp.s10~s18 (2002)
37. Schimmelmann BG, "Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies", World Psychiatry, 14, pp.189~197 (2015)[DOI]
38. McGorry PD, "The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey", Acta Psychiatr Scand, 92, pp.241~249 (1995)[DOI]
39. Fonseca-Pedrero E, "Assessing self-reported clinical high risk symptoms in community-derived adolescents: a psychometric evaluation of the Prodromal Questionnaire-Brief", Compr Psychiatry, 66, pp.201~208 (2016)[DOI]
40. McGorry P, "Why We need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment", JAMA Psychiatry, 73, pp.191~192 (2016)[DOI]

관련 논문AI추천